Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: BIKO: BICO

No earlier versions found for this Subject.

Return to BIKO: BICO

BICO (formerly Biocontrol Technology) aims to end pin-pricks. The company's Diasensor 2000 uses infrared light to measure glucose, eliminating the need to draw blood to check a diabetic's blood sugar level; it's cleared for sale in the European Union and is being evaluated by the FDA. BICO has received approval to sell its ThermoChem-HT system, a treatment for abdominal and pelvic tumors. The company's business units make a vascular-access system to administer medicine, an artificial heart valve, and a microbial oil-spill cleanup product. ViaCirQ, a subsidiary, develops extracorporeal hyperthermia medical devices.